Clinical Trial Update: A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial evaluating JS015 in combination therapy for advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• JS015

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING